BIOYF(BIOYF)
BIOYF
No analyst ratings available
No analyst price targets available for BIOYF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E | FY2027E | FY2028E |
|---|---|---|---|
| Revenue Avg | $69M | $83M | $90M |
| Low | $69M | $83M | $90M |
| High | $69M | $83M | $90M |
| EBITDA Avg | $19M | $23M | $25M |
| Low | $19M | $23M | $25M |
| High | $19M | $23M | $25M |
| EBIT Avg | $18M | $22M | $24M |
| Low | $18M | $22M | $24M |
| High | $18M | $22M | $24M |
| Net Income Avg | $10M | $12M | $14M |
| Low | $10M | $12M | $14M |
| High | $10M | $12M | $14M |
| EPS Avg | $0.86 | $1.05 | $1.22 |
| Low | $0.86 | $1.05 | $1.22 |
| High | $0.86 | $1.05 | $1.22 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 |
|---|---|---|
| Revenue Avg | $18M | $19M |
| Low | $18M | $19M |
| High | $18M | $19M |
| EBITDA Avg | $5M | $5M |
| Low | $5M | $5M |
| High | $5M | $5M |
| EBIT Avg | $5M | $5M |
| Low | $5M | $5M |
| High | $5M | $5M |
| Net Income Avg | — | — |
| Low | — | — |
| High | — | — |
| EPS Avg | — | — |
| Low | — | — |
| High | — | — |
| Analysts (Rev / EPS) | 1 / — | 1 / — |